Bone conduction Hearing Aid (BM100, BM300, BM310, SHOKZHEAR BM400, SHOKZ BM400MN, SHOKZHEAR BM410, SHOKZHEAR BM410MN, SHOKZHEAR BM420 and SHOKZHEAR BM420MN)
Shokz Health Global Limited · Decision date Aug 19, 2026
What did the FDA decide?
FDA records K253431 as a 510(k) premarket notification, with a decision dated Aug 19, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Ear, Nose, Throat
- Decision date
- Aug 19, 2026
Regulatory record facts
- Identifier
- K253431
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Shokz Health Global Limited
- Product code
- LXB
- Decision code
- SESE
- Decision date
- Aug 19, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Hearing Aid, Bone Conduction.
- Applicant
- Shokz Health Global Limited
- Product code
- LXB
- FDA device class
- 2
FDA decision timeline
K253431 received
Application receipt date recorded by FDA.
K253431 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code LXB
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Ossiclear (Ossiclear System)K254296 | Sounduct | 510(k) clearance | Jul 22, 2026 | FDA |
| Zdeer Technology (Henan) Co., Ltd. | 510(k) clearance | Jun 15, 2026 | FDA | |
| Shenzhen Magnet Technology Co., Ltd. | 510(k) clearance | Jun 11, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Shokz Health Global Limited
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Kowloon
Sources and methodology
- Original FDA record: K253431
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
